Abstract
Primary vesicoureteral reflux (VUR) is a controversial pathology. Current management of VUR is ruled by EAU guidelines elaborated in 2012. They defined and analyzed the risk factors and enunciated three risk groups, developing the initial treatment indications. Continuous antibiotic prophylaxis (CAP) is recommended as the initial treatment option in patients classified in moderate-risk group without low urinary tract disorder. The compliance with medication use is a concern for using CAP. The aim of the present study is to quantify the compliance of the parents of VUR patients, to analyze its impact on treatment and the applicability of EAU guidelines in our patients. This is a 4-year prospective study, which includes 202 patients aged between 1 and 174 months, diagnosed with primary VUR without LUTD. To quantify parent compliance with treatment, an algorithm was developed. Out of 202 children, 60.9% were girls. A rate of 54% patients was declared cured. In terms of compliance, incompliant patients tend toward worsening (p = 0.0001), most of them being unfollowed. Logistic regression demonstrated that the evolution of children with VUR is dependent on compliance. In conclusion, parent’s compliance must be considered in EAU guidelines application, being a negative predictive factor in VUR resolution.
Similar content being viewed by others
References
World Health Organization (2003) Adherence to long-term therapies: evidence for action. World Health Organisation, Geneva. ISBN 92-4-154599-2
Barat I, Andreasen F, Damsgaard EM (2001) Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol 51(6):615–622
Fischer MA, Stedman MR, Lii J et al (2010) Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med 25(4):284–290
Knudson MJ, Austin JC, McMillan ZM et al (2007) Predictive factors of early spontaneous resolution in children with primary vesicoureteral reflux. J Urol 178:1684–1688
Hannula A, Venhola M, Renko M et al (2010) Vesicoureteral reflux in children with suspected and proven urinary tract infection. Pediatr Nephrol 25:1463–1469
Garcia-Roig ML, Kirsch AJ (2016) Urinary tract infection in the setting of vesicoureteral reflux. F1000Research 5(F1000 Faculty Rev):1552. Last Updated 30 June 2016
Tekgul S, Riedmiller H, Hoebeke P et al (2012) EAU guidelines on vesicoureteral reflux in children. Eur Urol 62:534–542
Baquerizo BV, Peters C (2014) Antibiotic prophylaxis and reflux: critical review and assessment. F1000Prime Rep 6:104
Jimmy B, Jose J (2011) Patient medication adherence: measures in daily practice. Oman Med J 26(3):155–159
Wefer A, Gunnarsson U, Fränneby U, Sandblom G (2016) Patient-reported adverse events after hernia surgery and socio-economic status: a register-based cohort study. Int J Surg 35:100–103
Dianatinasab M, Fararouei M, Mohammadianpanah M, Zare-Bandamiri M (2016) Impact of social and clinical factors on diagnostic delay of breast cancer: a cross-sectional study. Medicine (Baltimore) 95(38):e4704
Jackson C, Dyson L, Bedford H et al (2016) Understanding uptake of immunisations in travelling and gypsy communities (UNITING): a qualitative interview study. Health Technol Assess 20(72):1–176
Nowak GJ, Cacciatore MA (2016) Parents’ confidence in recommended childhood vaccinations: extending the assessment, expanding the context. Hum Vaccin Immunother 28:1–14
Pogorelić Z, Gudelj K, Budimir D et al (2016) Comparison of dextranomer/hyaluronic acid based bulking agents in the treatment of vesicoureteral reflux in children: deflux versus vurdex. Can J Urol 23(3):8312–8317
Taşkinlar H, Avlan D, Bahadir GB, Delibaş A, Nayci A (2016) The outcomes of two different bulking agents (dextranomer hyaluronic acid copolymer and polyacrylate-polyalcohol copolymer) in the treatment of primary vesico-ureteral reflux. Int Braz J Urol 42(3):514–520
Abeysekara CK, Yasaratna BM, Abeyanunawardena AS (2006) Long-term clinical follow up of children with primary vesicoureteric reflux. Indian Pediatr 43(2):150–154
Festa RS, Tamaroff MH, Chasalow F, Lanzkowsky P (1992) Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment. J Pediatr 120(5):807–811
Macedo CS, Riyuzo MC, Bastos HD (2003) Renal scars in children with primary vesicoureteric reflux. J Pediatr (Rio J) 79:355–362
Menon P, Rao KLN, Bhattacharya A, Mahajan JK, Samujh R (2004) Primary vesicoureteric reflux: progress of disease, somatic growth and renal parameters. Indian Pediatr 41:1025–1030
Jayanthi V, Patel A (2008) Vesicoscopic ureteral reimplantation: a minimally invasive technique for the definitive repair of vesicoureteral reflux. Adv Urol 973616. doi:10.1155/2008/973616
Rodríguez AB, Ramos FJM, Sánchiz CS et al (2016) Renal scarring in children under 36 months hospitalised for acute pyelonephritis. An Pediatr (Barc) 86(2):76–80
Gupta P, Mandal J, Krishnamurthy S et al (2015) Profile of urinary tract infections in paediatric patients. Indian J Med Res 141(4):473–477
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prisca, R.A., Gozar, H., Prisca, A.M. et al. Parent compliance: a bad predictor of resolution and a problem in the application of EAU guidelines on vesicoureteral reflux in children. Int Urol Nephrol 49, 741–745 (2017). https://doi.org/10.1007/s11255-017-1551-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-017-1551-9